Hyaluronic acid (HA) is a non-sulfated polysaccharide polymer with the properties of biodegradability, biocompatibility, and non-toxicity. Additionally, HA specifically binds to certain receptors that are over-expressed in cancer cells. To maximize the effect of drug delivery and cancer treatment, diverse types of nanomaterials have been developed. HA-based nanomaterials, including micelles, polymersomes, hydrogels, and nanoparticles, play a critical role in efficient drug delivery and cancer treatment. Hyperthermic cancer treatment using HA-based nanomaterials has attracted attention as an efficient cancer treatment approach. In this paper, the biomedical applications of HA-based nanomaterials in hyperthermic cancer treatment and combined therapies are summarized. HA-based nanomaterials may become a representative platform in hyperthermic cancer treatment.
CITATION STYLE
Kim, S., Moon, M. J., Surendran, S. P., & Jeong, Y. Y. (2019, July 1). Biomedical applications of hyaluronic acid-based nanomaterials in hyperthermic cancer therapy. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics11070306
Mendeley helps you to discover research relevant for your work.